Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-01-03 Sale | 2025-01-07 8:02 pm | AN2 Therapeutics Inc. | ANTX | Day Lucy Chief Financial Officer | 2,957 | $1.341 | $3,965 | 32,670 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-02-26 Option Award | 2025-02-28 4:26 pm | N/A 2035-02-25 | AN2 Therapeutics Inc. | ANTX | Day Lucy Chief Financial Officer | 139,500 | $0 | 172,170 (Direct) | View |
| 2024-03-15 Option Award(A) | 2024-03-29 4:18 pm | N/A N/A | AN2 Therapeutics Inc. | ANTX | Day Lucy Chief Financial Officer | 27,500 | $0 | 30,627 (Direct) | View |
| 2024-03-15 Option Award | 2024-03-18 7:29 pm | N/A 2034-03-14 | AN2 Therapeutics Inc. | ANTX | Day Lucy Chief Financial Officer | 82,500 | $0 | 85,627 (Direct) | View |
| 2023-02-15 Option Award | 2023-02-17 7:29 pm | N/A 2033-02-14 | AN2 Therapeutics Inc. | ANTX | Day Lucy Chief Financial Officer | 82,300 | $0 | 82,300 (Direct) | View |
| 2022-05-12 Option Award | 2022-05-16 9:15 pm | N/A 2032-05-11 | AN2 Therapeutics Inc. | ANTX | Day Lucy Chief Financial Officer | 66,000 | $0 | 66,000 (Direct) | View |
Ownership | 2022-03-24 9:19 pm | N/A 2030-01-22 | AN2 Therapeutics Inc. | ANTX | Day Lucy Chief Financial Officer | 0 | $0 | 141,668 (Direct) | View |